Wei Tong
Impact in
- Genetics top 0.2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
Papers in
- Hematology 32
- Acute Myeloid Leukemia Research 16
- Platelet Disorders and Treatments 10
- Hematopoietic Stem Cell Transplantation 8
- Chronic Myeloid Leukemia Treatments 8
- Genetics 21
- Myeloproliferative Neoplasms: Diagnosis and Treatment 15
- Chronic Lymphocytic Leukemia Research 6
- Co-authors
- Harvey F. LodishJeffrey W. PollardRoss L. LevineD. Gary GillilandAlexey BersenevChao WuMary Frances McMullinAlan J. Warren
- Journals
- Blood (16 papers)Journal of Clinical Investigation (8 papers)Genes & Development (5 papers)The Journal of Experimental Medicine (2 papers)Experimental Hematology (2 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Wei Tong
82 papers receiving 5.5k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Genetics 1.8k
- Hematology 1.7k
- Immunology 1.1k
- Molecular Biology 2.7k
- Cancer Research 576
Countries citing papers authored by Wei Tong
This map shows the geographic impact of Wei Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Tong more than expected).
Fields of papers citing papers by Wei Tong
This network shows the impact of papers produced by Wei Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Tong. The network helps show where Wei Tong may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Tong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 25 | |
| 4 | 2023 | 14 | |
| 5 | 2023 | 24 | |
| 6 | 2022 | 9 | |
| 7 | 2021 | 43 | |
| 8 | 2021 | 21 | |
| 9 | 2021 | 4 | |
| 10 | 2021 | 42 | |
| 11 | 2020 | 3 | |
| 12 | SIRT1 is downregulated by autophagy in senescence and ageing Hit paper breakdown → | 2020 | 357 |
| 13 | 2019 | 17 | |
| 14 | 2014 | 1 | |
| 15 | 2012 | 11 | |
| 16 | 2010 | 53 | |
| 17 | 2010 | 85 | |
| 18 | Epidermal Growth Factor Receptor (EGFR) tyrosine kinase activity attenuates TNF-stimulated intestinal cell apoptosis | 2006 | 0 |
| 19 | 2006 | 287 | |
| 20 | A macrophage colony-stimulating factor receptor–green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse Hit paper breakdown → | 2003 | 513 |
About Wei Tong
Wei Tong is a scholar working on Hematology, Genetics, Immunology, Oncology and Molecular Biology, having authored 84 papers that have together received 5.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (16 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers), Platelet Disorders and Treatments (10 papers), Hematopoietic Stem Cell Transplantation (8 papers), Chronic Myeloid Leukemia Treatments (8 papers), Cytokine Signaling Pathways and Interactions (6 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Acute Lymphoblastic Leukemia research (5 papers). The work is most often cited by research in Genetics (1.8k citations), Hematology (1.7k citations), Immunology (1.1k citations), Molecular Biology (2.7k citations) and Cancer Research (576 citations). Wei Tong has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Harvey F. Lodish, Jeffrey W. Pollard, Ross L. Levine, D. Gary Gilliland, Alexey Bersenev, Chao Wu, Mary Frances McMullin, Alan J. Warren, Wendy N. Erber and Linda M. Scott. Their work appears in journals such as Blood, Journal of Clinical Investigation, Genes & Development, The Journal of Experimental Medicine and Experimental Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.